Signaling pathways
-
BA8740 ZandelisibSummary: Zandelisib (ME-401) is an inhibitor. -
BA8741 PIK-108Summary: A non-ATP-competitive, metastable/selective inhibitor. - BA8742 PI4KIIIbeta-IN-9Summary: PI4KIIIbeta-IN-9 is a potent inhibitor.
- BA8743 GDC-0326Summary: GDC-0326 is a potent, selective inhibitor.
- BA8744 SeletalisibSummary: Seletalisib (UCB5857) is a potent and selective inhibitor.
- BA8745 SAR-260301Summary: SAR-260301 is a potent, selective inhibitor with oral activity.
- BA8746 PI3K-IN-31Summary: PI3K-IN-31 is a potent inhibitor.
- BA8747 PF-06843195Summary: PF-06843195 is a highly selective inhibitor.
- BA8748 AZD8154Summary: AZD8154 is a novel inhaled selective dual inhibitor.
- BA8749 GSK-F1Summary: GSK-F1 is an orally active inhibitor.